ONCO supply chain intelligence for Onconetix, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Onconetix, Inc. (ONCO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in … |
| ABT | Abbott Laboratories | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| MDXH | MDxHealth SA | 72% | Reciprocal relationship from MDXH graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from MDXH graph: Reciprocal relationship from ONCO graph: me of which possess substantially g… |
| MDXH | MDxHealth SA | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| OPK | OPKO Health, Inc. | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| OPK | OPKO Health, Inc. | 72% | Reciprocal relationship from OPK graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in … |
| TECH | Bio-Techne Corporation | 72% | Reciprocal relationship from TECH graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from TECH graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from TECH g… |
| TECH | Bio-Techne Corporation | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| XYF | X Financial | 72% | Reciprocal relationship from XYF graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from XYF graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from XYF grap… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| IMMUNOVIA | IMMUNOVIA | 92% | For the year ended December 31, 2025, 100% of our development service revenue, 100% of our other revenue, and 92% of our product sales revenue came from Immunovia |
| PROTEOMEDIX | PROTEOMEDIX | 92% | Proteomedix provides a range of services to life sciences customers referred to as "Development Services" |
| CAMBRIDGE | CAMBRIDGE | 90% | 3% of our remaining product sales revenue came from Cambridge |
| LABCORP | LABCORP | 90% | 73% of our product sales revenue came from LabCorp |
| ZENTRUM-FUR-LABORMEDIZI | ZENTRUM-FUR-LABORMEDIZI | 90% | 5% of our remaining product sales revenue came from Zentrum fur Labormedizi |
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ONCO graph: me of which possess substantially gre… |
| ABT | Abbott Laboratories | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| MDXH | MDxHealth SA | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| MDXH | MDxHealth SA | 72% | Reciprocal relationship from MDXH graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in… |
| OPK | OPKO Health, Inc. | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| OPK | OPKO Health, Inc. | 72% | Reciprocal relationship from OPK graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from OPK graph: Reciprocal relationship from ONCO graph: me of which possess substantially gre… |
| TECH | Bio-Techne Corporation | 72% | Reciprocal relationship from TECH graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in… |
| TECH | Bio-Techne Corporation | 72% | me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and greater market penetration, purchasing power… |
| XYF | X Financial | 72% | Reciprocal relationship from XYF graph: Reciprocal relationship from ONCO graph: and results are available quickly. Local diagnostic laboratories can integrate this multiparametric test into their cu… |
| XYF | X Financial | 72% | and results are available quickly. Local diagnostic laboratories can integrate this multiparametric test into their current workflow because Proclarix assays use the enzyme-linked immunosorbent assay… |
| ALTOS-VENTURE-AG | ALTOS-VENTURE-AG | 62% | e or in part, any of the economic consequences of ownership of the Exchange Shares or the Conversion Shares, or (iii) publicly disclose the intention to do any of the foregoing, whether any such tran… |
| AMERICA-HOLDINGS | AMERICA-HOLDINGS | 62% | e or in part, any of the economic consequences of ownership of the Exchange Shares or the Conversion Shares, or (iii) publicly disclose the intention to do any of the foregoing, whether any such tran… |
| BLUE-WATER-BIOTECH-INC | BLUE-WATER-BIOTECH-INC | 62% | ate of Delaware to change its corporate name from “Blue Water Biotech, Inc.” to “Onconetix, Inc.” In connection with each of the name changes, the Company also amended the Company’s bylaws to reflect… |
| BLUE-WATER-VACCINES-INC | BLUE-WATER-VACCINES-INC | 62% | me and resources needed to continue pursuing commercialization of ENTADFI, and (ii) the Company’s cash runway and indebtedness, the Company abandoned commercialization of ENTADFI and the ENTADFI asse… |
| KEYSTONE-CAPITAL-PARTNERS-LLC | KEYSTONE-CAPITAL-PARTNERS-LLC | 62% | the September Veru Note is paid in full; ● Any amounts owed on the September Veru Note, including but not limited to unpaid principal and accrued interest, will be paid in cash or, upon the mutual wr… |
| REALBOTIX-LLC | REALBOTIX-LLC | 62% | grams, and accordingly, we now operate in one segment: commercial. The commercial segment was new in the second quarter of 2023 and is currently dedicated to the development and commercialization of … |
| REPORT-LABORATORY-CORPORATION | REPORT-LABORATORY-CORPORATION | 62% | eries E Warrants at the Variable Price. Additionally, the Warrant Limited Waiver waived the right of the Series D Warrants and the Series E Warrants to receive a guaranteed cash payment in connection… |
| WARRANT-LIMITED | WARRANT-LIMITED | 62% | eries E Warrants at the Variable Price. Additionally, the Warrant Limited Waiver waived the right of the Series D Warrants and the Series E Warrants to receive a guaranteed cash payment in connection… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ONCO-DEBT-11528 | Warrants outstanding: 3729 | 90% | xbrl warrant detail from xbrl 2025-12-23. |
| ONCO-DEBT | Debt stack $289,922 | 90% | Market cache reports total debt of $289,922. |
| ONCO-DEBT-11529 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| Acquired Entity | Name | Confidence | Evidence |
|---|---|---|---|
| ONCO-ACQ-0001213900-26-015212 | Onconetix will issue shares of common stock to acquire Realbotix. | 85% | Onconetix will issue shares of common stock to acquire Realbotix. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ONCO-OWNER-DRW-SECURITIES-LLC | DRW Securities, LLC | 95% | 13F/ownership overlay lists DRW Securities, LLC; shares held 39,046; ownership 1.09%; value $75,749; as of 2025-12-31. |
| ONCO-OWNER-XTX-TOPCO-LTD | Xtx Topco Ltd | 95% | 13F/ownership overlay lists Xtx Topco Ltd; shares held 10,827; ownership 0.30%; value $21,004; as of 2025-12-31. |
| ONCO-OWNER-UBS-GROUP-AG | UBS Group AG | 95% | 13F/ownership overlay lists UBS Group AG; shares held 9,203; ownership 0.26%; value $17,853; as of 2025-12-31. |
| ONCO-OWNER-SBI-SECURITIES-CO-LTD | SBI Securities Co., Ltd. | 95% | 13F/ownership overlay lists SBI Securities Co., Ltd.; shares held 154; value $298; as of 2025-12-31. |
| ONCO-OWNER-TOWER-RESEARCH-CAPITAL-LLC-TRC | Tower Research Capital LLC (TRC) | 95% | 13F/ownership overlay lists Tower Research Capital LLC (TRC); shares held 1,819; ownership 0.05%; value $3,528; as of 2025-12-31. |
| ONCO-OWNER-BANK-OF-AMERICA-CORPORATION | Bank of America Corporation | 95% | 13F/ownership overlay lists Bank of America Corporation; shares held 11; value $21; as of 2025-12-31. |
| ONCO-OWNER-DANSKE-BANK-A-S | Danske Bank A/s | 95% | 13F/ownership overlay lists Danske Bank A/s; shares held 1; value $1; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| FCCN | Spectral Capital Corporation | 100.00 | 2 | |
| HBNB | Hotel101 Global Holdings Corp. | 100.00 | 2 | |
| CIB | Grupo Cibest S.A. | 100.00 | 2 | |
| ETOR | eToro Group Ltd. | 100.00 | 2 | |
| AHG | Akso Health Group | 100.00 | 2 | |
| XRX | Xerox Holdings Corporation | 100.00 | 2 | |
| FENG | Phoenix New Media Limited | 100.00 | 2 | |
| CSTE | Caesarstone Ltd. | 100.00 | 2 | |
| GEMI | Gemini Space Station, Inc. | 100.00 | 2 | |
| AMBR | Amber International Holding Limited | 100.00 | 2 | |
| BTDR | Bitdeer Technologies Group | 100.00 | 2 | |
| BLNE | Beeline Holdings, Inc. | 100.00 | 2 | |
| RYAN | Ryan Specialty Holdings, Inc. | 100.00 | 2 | |
| CRMZ | CreditRiskMonitor.com, Inc. | 100.00 | 2 | |
| CANG | Cango Inc. | 100.00 | 2 | |
| ENLT | Enlight Renewable Energy Ltd | 100.00 | 2 | |
| BGC | BGC Group, Inc. | 100.00 | 2 | |
| BRBI | BRBI BR Partners S.A. | 100.00 | 2 | |
| BLSH | Bullish | 100.00 | 2 | |
| ABT | Abbott Laboratories | 100.00 | 1 | ['customer', 'supplier'] |